International Association for the Study of Lung Cancer/ American Thoracic Society/European Respiratory Society: International multidisciplinary classification of lung adenocarcinoma - An executive summary

Proceedings of the American Thoracic Society

Volumn 8, Issue 5, 2011, Pages 381-385

  Travis, William D ^a   Brambilla, Elisabeth ^b   Noguchi, Masayuki ^c   Nicholson, Andrew G ^d   Geisinger, Kim ^e   Yatabe, Yasushi ^f   Powell, Charles A ^g   Beer, David ^h   Riely, Greg ^a   Garg, Kavita ⁱ   Austin, John H M ^g   Rusch, Valerie W ^a   Hirsch, Fred R ^j   Jett, James ^k   Yang, Pan Chyr ^l   Gould, Michael ^m  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b GRENOBLE UNIVERSITY HOSPITAL   (France)

^c UNIVERSITY OF TSUKUBA   (Japan)

^d NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^e WAKE FOREST SCHOOL OF MEDICINE   (United States)

^f AICHI CANCER CENTER HOSPITAL   (Japan)

^g Och Spine at New York Presbyterian Hospitals   (United States)

^h UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

ⁱ UNIVERSITY OF COLORADO HOSPITAL   (United States)

^j UNIVERSITY OF COLORADO CANCER CENTER   (United States)

^k DEPARTMENT OF MEDICINE   (United States)

^l NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^m UNIVERSITY OF CALIFORNIA   (United States)

more..

Author keywords

Acinar; Adenocarcinoma; Adenocarcinoma in situ; Bronchioloalveolar carcinoma; Classification; Clear cell; Colloid; Computed tomography; EGFR; EML4 ALK; Enteric; Fetal; Frozen section; Gene amplification; Gene profiling; Histologic; KRAS; Lepidic; Limited resection; Lung; Micropapillary; Minimally invasive adenocarcinoma; Molecular; Mucinous cystadenocarcinoma; Oncology; Papillary; Pathology; Pulmonary; Radiology; Signet ring; Solid; Surgery; TTF 1, p63

Indexed keywords

BEVACIZUMAB; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR; PEMETREXED;

ARTICLE; CANCER CLASSIFICATION; CANCER PATIENT; CANCER STAGING; CARCINOMA IN SITU; CYTOLOGY; GOOD CLINICAL PRACTICE; HISTOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LUNG ADENOCARCINOMA; LUNG BIOPSY; LUNG NON SMALL CELL CANCER; MEDICAL SOCIETY; MICROSCOPY; MUTATION; PRACTICE GUIDELINE; RISK FACTOR; SQUAMOUS CELL CARCINOMA; SYSTEMATIC REVIEW; TISSUE SECTION; TREATMENT OUTCOME; WESTERN HEMISPHERE;

ADENOCARCINOMA; HUMANS; LUNG NEOPLASMS; TERMINOLOGY AS TOPIC;

EID: 80053023874     PISSN: 15463222     EISSN: 19435665     Source Type: Journal    
DOI: 10.1513/pats.201107-042ST     Document Type: Article

References (1)

1. Travis WD, Brambilla E, Noguchi M, Geisinger KR, Beer D, Powell CA, Johnson B, Riely GJ, Rusch VW, Asamura H, et al. The new IASLC/ ATS/ERS international multidisciplinary lung adenocarcinoma classification. J Thorac Oncol 2011;6:244-285.